Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Bumetanide measurement |
Component |
True |
Bumetanide (substance) |
Inferred relationship |
Some |
1 |
Bumetanide adverse reaction |
Causative agent (attribute) |
True |
Bumetanide (substance) |
Inferred relationship |
Some |
1 |
Allergy to bumetanide |
Causative agent (attribute) |
False |
Bumetanide (substance) |
Inferred relationship |
Some |
|
Bumetanide overdose |
Causative agent (attribute) |
True |
Bumetanide (substance) |
Inferred relationship |
Some |
1 |
Accidental bumetanide overdose |
Causative agent (attribute) |
True |
Bumetanide (substance) |
Inferred relationship |
Some |
1 |
Intentional bumetanide overdose |
Causative agent (attribute) |
True |
Bumetanide (substance) |
Inferred relationship |
Some |
1 |
surdose de bumétanide d'intention indéterminée |
Causative agent (attribute) |
False |
Bumetanide (substance) |
Inferred relationship |
Some |
1 |
Bumetanide 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bumetanide (substance) |
Inferred relationship |
Some |
|
Bumetanide 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bumetanide (substance) |
Inferred relationship |
Some |
|
Product containing precisely bumetanide 200 microgram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bumetanide (substance) |
Inferred relationship |
Some |
|
bumétanide 500 microgrammes/mL, ampoule de 4 mL pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bumetanide (substance) |
Inferred relationship |
Some |
|
Product containing bumetanide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bumetanide (substance) |
Inferred relationship |
Some |
1 |
Bumetanide-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bumetanide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely bumetanide 500 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bumetanide (substance) |
Inferred relationship |
Some |
|
Bumetanide 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bumetanide (substance) |
Inferred relationship |
Some |
|
Bumetanide 0.25mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bumetanide (substance) |
Inferred relationship |
Some |
|
Product containing bumetanide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bumetanide (substance) |
Inferred relationship |
Some |
1 |
Amiloride hydrochloride 5 mg and bumetanide 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bumetanide (substance) |
Inferred relationship |
Some |
|
Bumetanide+potassium 500mcg/7.7Mmol m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bumetanide (substance) |
Inferred relationship |
Some |
|
Amiloride hydrochloride+bumetanide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bumetanide (substance) |
Inferred relationship |
Some |
|
Product containing bumetanide and potassium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bumetanide (substance) |
Inferred relationship |
Some |
1 |
Bumetanide 0.25mg/mL injection solution 2mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bumetanide (substance) |
Inferred relationship |
Some |
|
Bumetanide 0.25mg/mL injection solution 4mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bumetanide (substance) |
Inferred relationship |
Some |
|
Bumetanide 0.25mg/mL injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bumetanide (substance) |
Inferred relationship |
Some |
|
Product containing amiloride and bumetanide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bumetanide (substance) |
Inferred relationship |
Some |
1 |
Allergy to bumetanide |
Causative agent (attribute) |
True |
Bumetanide (substance) |
Inferred relationship |
Some |
1 |
Bumetanide 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bumetanide (substance) |
Inferred relationship |
Some |
1 |
Bumetanide 1 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Bumetanide (substance) |
Inferred relationship |
Some |
1 |
Bumetanide 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bumetanide (substance) |
Inferred relationship |
Some |
1 |
Bumetanide 5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Bumetanide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely bumetanide 500 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bumetanide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely bumetanide 500 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Bumetanide (substance) |
Inferred relationship |
Some |
1 |
Bumetanide 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bumetanide (substance) |
Inferred relationship |
Some |
1 |
Bumetanide 2 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Bumetanide (substance) |
Inferred relationship |
Some |
1 |
Amiloride hydrochloride 5 mg and bumetanide 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bumetanide (substance) |
Inferred relationship |
Some |
1 |
Amiloride hydrochloride 5 mg and bumetanide 1 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Bumetanide (substance) |
Inferred relationship |
Some |
1 |
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Bumetanide (substance) |
Inferred relationship |
Some |
2 |
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Bumetanide (substance) |
Inferred relationship |
Some |
2 |
Bumetanide 2 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Bumetanide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely bumetanide 500 microgram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Bumetanide (substance) |
Inferred relationship |
Some |
1 |
Bumetanide 1 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Bumetanide (substance) |
Inferred relationship |
Some |
1 |
Bumetanide 5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Bumetanide (substance) |
Inferred relationship |
Some |
1 |
Amiloride- and bumetanide-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bumetanide (substance) |
Inferred relationship |
Some |
1 |
Amiloride hydrochloride 5 mg and bumetanide 1 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Bumetanide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely bumetanide 200 microgram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Bumetanide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely bumetanide 200 microgram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Bumetanide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely bumetanide 2 milligram/4 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Bumetanide (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely bumetanide 2 milligram/4 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Bumetanide (substance) |
Inferred relationship |
Some |
1 |
Bumetanide- and potassium chloride-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bumetanide (substance) |
Inferred relationship |
Some |
1 |
Bumetanide- and potassium chloride-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bumetanide (substance) |
Inferred relationship |
Some |
1 |
Product containing only bumetanide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bumetanide (substance) |
Inferred relationship |
Some |
1 |
Product containing only amiloride and bumetanide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bumetanide (substance) |
Inferred relationship |
Some |
1 |
Bumetanide and potassium only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bumetanide (substance) |
Inferred relationship |
Some |
1 |
Bumetanide and potassium chloride only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bumetanide (substance) |
Inferred relationship |
Some |
1 |
Amiloride and bumetanide only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bumetanide (substance) |
Inferred relationship |
Some |
1 |
Bumetanide and potassium chloride only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bumetanide (substance) |
Inferred relationship |
Some |
1 |
Bumetanide only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bumetanide (substance) |
Inferred relationship |
Some |
1 |
Bumetanide only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bumetanide (substance) |
Inferred relationship |
Some |
1 |
Bumetanide 500 microgram/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Bumetanide (substance) |
Inferred relationship |
Some |
1 |
Bumetanide 500 microgram/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Bumetanide (substance) |
Inferred relationship |
Some |
1 |
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Bumetanide (substance) |
Inferred relationship |
Some |
1 |
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Bumetanide (substance) |
Inferred relationship |
Some |
1 |